Sequencing by orthogonal synthesis

• US 9,574,235 B2
• Filed: 10/29/2015
• Issued: 02/21/2017
• Est. Priority Date: 07/03/2013
• Status: Active Grant

• Current Assignee: Illumina Incorporated
• Original Assignee: Illumina Incorporated
• Inventors: Fabani, Martin Maria, Rogert Bacigalupo, Maria Candelaria, Moon, John A.
• Primary Examiner(s): THOMAS, DAVID C
• Application Number:
  US14/926,368
• Publication Number:
  US 20160115533A1
• Time in Patent Office: 481 Days
• Field of Search: None
• US Class Current: 1/1
• CPC Class Codes: C07H 21/02 with ribosyl as saccharide radical
• CPC Class Codes: C07H 21/04 with deoxyribosyl as saccharide radical
• CPC Class Codes: C12N 9/00 Enzymes; Proenzymes; Compositions thereof preparations containing enzymes for cleaning teeth A61K8/66, A61Q11/00; medicinal preparations containing enzymes or proenzymes A61K38/43; enzyme containing detergent compositions C11D; enzymes with nucleic acid structure, e.g. ribozymes, C12N15/113; Processes for preparing, activating, inhibiting, separating or purifying enzymes preparation of malt C12C1/00
• CPC Class Codes: C12P 19/30 Nucleotides
• CPC Class Codes: C12Q 1/6869 Methods for sequencing
• CPC Class Codes: C12Q 1/6874 involving nucleic acid arrays, e.g. sequencing by hybridisation
• CPC Class Codes: C12Q 2521/101 DNA polymerase
• CPC Class Codes: C12Q 2521/119 RNA polymerase
• CPC Class Codes: C12Q 2525/101 incorporating non-naturally occurring nucleotides, e.g. inosine
• CPC Class Codes: C12Q 2533/101 Primer extension
• CPC Class Codes: C12Q 2533/107 Probe or oligonucleotide ligation
• CPC Class Codes: C12Q 2535/122 Massive parallel sequencing
• CPC Class Codes: C12Q 2565/507 characterised by the density of the capture oligonucleotide
• CPC Class Codes: C12Q 2565/518 characterised by the immobilisation of the nucleic acid sample or target
• CPC Class Codes: C12Q 2565/537 characterised by the capture oligonucleotide acting as a primer

Abstract

A method for sequencing includes steps of (a) providing first and second nucleic acid templates, wherein the two templates have different sequences; (b) extending a first primer bound to the first template using a first polymerase species and a first set of nucleotide analogs; (c) extending a second primer bound to the second template using a second polymerase species and a second set of nucleotide analogs, wherein the first polymerase species is different from the second polymerase species and wherein the first set of nucleotide analog is different from the second set of nucleotide analog, (d) detecting the first and second primer extension products; and (e) repeating steps (b) through (d), thereby determining the different sequences of the first and second templates.

Claims

1. A system for sequencing nucleic acid templates, the system comprising:

(a) an array of sites, wherein each site comprises a first nucleic acid template and a second nucleic acid template, wherein the first nucleic acid template comprises a DNA primer bound to the first template, and wherein the second nucleic acid template comprises an RNA primer bound to the second template;

(b) a DNA polymerase species suitable for extending the DNA primer bound to the first template;

(c) an RNA polymerase suitable for extending the RNA primer bound to the second template;

(d) a set of deoxyribonucleotide analogs suitable for producing a DNA primer extension product extending from the DNA primer, wherein the extension product comprises a deoxyribonucleotide analog at each of the sites;

(e) a set of ribonucleotide analogs suitable for producing an RNA primer extension product extending from the RNA primer, wherein the extension product comprises a ribonucleotide analog at each of the sites; and

(f) a detector for detecting the DNA primer extension product and the RNA primer extension product.

2. The system of claim 1, wherein the detector comprises a spatial resolution that is too low to resolve points at a distance equivalent to the spacing between the DNA primer extension product and the RNA primer extension product at each of the sites.

3. The system of claim 2, wherein the detector is an optical detector.

4. The system of claim 1, wherein the nucleotide analogs comprise optical labels.

5. The system of claim 4, wherein the optical labels of the set of deoxyribonucleotide analogs are different from the optical labels of the set of ribonucleotide analogs.

6. The system of claim 5, wherein a subset of the nucleotide analogs in the set of deoxyribonucleotide analogs comprise optical labels.

7. The system of claim 5, wherein a subset of the nucleotide analogs in the set of ribonucleotide analogs comprise optical labels.

8. The system of claim 5, wherein the set of deoxyribonucleotide analogs comprise only one type of optical label that is detected in step (d) and the set of ribonucleotide analogs comprise only one type of optical label that is detected in step (d).

9. The system of claim 8, wherein the one type of optical label is attached to substantially all of the nucleotide analogs of a first species in the set of deoxyribonucleotide analogs,

the one type of optical label is attached to a subset of the nucleotide analogs of a second species in the set of deoxyribonucleotide analogs,

substantially all of the nucleotide analogs of a third species in the set of deoxyribonucleotide analogs are attached to a ligand, and

substantially all of the nucleotide analogs of a fourth species in the set of deoxyribonucleotide analogs are not attached to the one type of optical label or to the ligand.

10. The system of claim 5, wherein the set of deoxyribonucleotide analogs comprise only two types of optical labels that are detected in step (d) and the set of ribonucleotide analogs comprise only two types of optical labels that are detected in step (d).

11. The system of claim 10, wherein only one of the two types of optical labels is attached to substantially all of the nucleotide analogs of a first species in the set of deoxyribonucleotide analogs,

only a second of the two types of optical labels is attached to substantially all of the nucleotide analogs of a second species in the set of deoxyribonucleotide analogs,

the one of the two types of optical labels and the second of the two types of optical labels are attached to nucleotide analogs of a third species in the set of deoxyribonucleotide analogs, and

substantially all of the nucleotide analogs of a fourth species in the set of deoxyribonucleotide analogs are not attached to the one of the two types of optical labels or the second of the two types of optical labels.

12. The system of claim 2, wherein a pixel of the detector acquires signals from both the DNA primer extension product and the RNA primer extension product.

13. The system of claim 1, wherein the first nucleic acid template comprises at least one base moiety that is the same species as a base moiety in the second nucleic acid template.

14. The system of claim 13, wherein the first nucleic acid template and the second nucleic acid template comprise DNA.

15. The system of claim 13, wherein the at least one base moiety is selected from the group consisting of adenine, thymine, cytosine, and guanine.

16. The system of claim 1, wherein a single nucleic acid molecule contains the first nucleic acid template and the second nucleic acid template.

17. The system of claim 1, wherein the first nucleic acid template and the second nucleic acid template are on different nucleic acid molecules.

18. The system of claim 1, wherein the sites have an area that is no greater than 100 μ

m².

19. The system of claim 1, wherein the sites comprise multiple copies of the first nucleic acid template and the second nucleic acid template.

20. The system of claim 19, wherein the multiple copies comprise a nucleic acid cluster.

21. The system of claim 1, wherein the DNA polymerase is selective for the first template compared to the second template and wherein the RNA polymerase is selective for the second template compared to the first template.

22. An array for orthogonal sequencing of nucleic acid templates, the array comprising:

(a) a plurality of sites, each site comprising;

i) a first nucleic acid template hybridized to a DNA primer, wherein the primer comprises at least one deoxyribonucleotide analog incorporated by a DNA polymerase species suitable for extending the DNA primer bound to the first nucleic acid template;

ii) a second nucleic acid template hybridized to a RNA primer, wherein the primer comprises at least one ribonucleotide analog incorporated by a RNA polymerase species suitable for extending the RNA primer bound to the second nucleic acid template;

(b) optionally a DNA polymerase species suitable for extending the DNA primer bound to the first template;

(c) optionally an RNA polymerase suitable for extending the RNA primer bound to the second template;

(d) optionally a set of deoxyribonucleotide analogs suitable for producing a DNA primer extension product extending from the DNA primer, wherein the extension product comprises a deoxyribonucleotide analog at each of the sites;

(e) optionally a set of ribonucleotide analogs suitable for producing an RNA primer extension product extending from the RNA primer, wherein the extension product comprises a ribonucleotide analog at each of the sites; and

(f) optionally a detector for detecting the DNA primer extension product and the RNA primer extension product.